AGP Executive Report
Last update: 3 hours agoGLP-1 Legal Clash: Novo Nordisk filed a federal lawsuit in New Jersey against Eli Lilly, accusing Lilly of “deceptive” nationwide ads that compare Zepbound/Mounjaro highest doses to older, lower-dose versions of Wegovy/Ozempic—Novo says the claims use outdated trial data and omit newer context. Food Safety Alert: A cyclosporiasis-linked iceberg lettuce recall continues to affect shoppers in New Jersey and 26 other states, but FDA says some lab results were a false positive—health experts stress you should avoid only the specific recalled products and check packaging. Drug Recall: A New Jersey-based company, Rising Pharma Holdings, issued a voluntary recall of certain 5 mg cetirizine tablets after possible cross-contamination with ranitidine, which could trigger life-threatening allergic reactions. Health Coverage Proposal: Sen. Andy Kim (D-NJ) unveiled the MediKids Act, a long-shot plan to automatically enroll every child in federally funded coverage from birth through age 26. Behavioral Health Expansion: Beacon Behavioral Partners expanded into Michigan and Ohio through a deal with Pure Psychiatry, adding 17 outpatient locations.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
